Ismail Okan Yildirim, Kaya Sarac, Mehmet Tan, Tuba Bayindir, Mehmet Turan Cicek, Mehmet Aslan, Ebru Ozer Ozturk

Angiographic embolization in epistaxis: Our clinical experience and results

Aim: Nosebleed, more commonly called epistaxis is a general clinical problem, and the most of bleedings can be treated non-invasive approach. However, because of persistent and sometimes life-threatening bleeding, additional treatment such as super-selective embolization may be required. In this study, we report our data on the endovascular treatment of persistent epistaxis. Materials and Methods: Between January 2010 and December 2019, all patients who were followed up at Inonu University Turgut Ozal Medical Center Otorhinolaryngology Clinic due to recurrent persistent nosebleed and required endovascular treatment were retrospectively screened. Demographic data, cause of epistaxis, localization of the bleeding, the clinical significance of the bleeding, interventional approach, complications related to treatment, and results were evaluated. Results: All of 18 patients with intractable epistaxis were included in the study. Depending on the etiology of epistaxis, patients were determined into three groups: idiopathic epistaxis (10/18), iatrogenic or traumatic epistaxis (7/18), and nasopharyngeal cancer (1/18). Nine of 18 patients required blood transfusions. The internal maxillary artery was embolized unilaterally in 12 of 18 (66%) and bilaterally in 2 of 18 (11%) procedures. Four patients were not embolized because of bleeding originated from ethmoidal branches of the ophthalmic artery. These four patients were operated on (endoscopic ethmoidectomy and bleeding control). Long-term success rates of embolization were 14 of 14. Major complications (transient hemiparesis) occurred in one patient after embolization. Conclusion: Endovascular approach proves to be effective for intractable and fatal epistaxis. Embolization has a good risk-benefit ratio in persistent bleeding. However, if bleeding is originated by the ethmoidal branches of the ophthalmic artery, embolization may not be performed to avoid visual complications.

PDF

___

1. Schaitkin B, Strauss M, Houck JR. Epistaxis: medical versus surgical therapy: a comparison of efficacy, complications, and economic considerations. Laryngoscope 1987;97:1392-6.
2. Small M, Murray JA, Maran AG. A study of patients with epistaxis requiring admission to hospital. Health Bull (Edinb) 1982;40:20-9.
3. Leppanen M, Seppanen S, Laranne J et al. Microcatheter embolization of intractable idiopathic epistaxis. Cardiovasc Intervent Radiol 1999;22:499- 503.
4. Pope LE, Hobbs CG. Epistaxis: an update on current management. Postgrad Med J 2005;81:309-14.
5. Willems PW, Farb RI, Agid R. Endovascular treatment of epistaxis. AJNR Am J Neuroradiol 2009;30:1637- 45.
6. Strach K, Schrock A, Wilhelm K. Endovascular treatment of epistaxis: Indications, management, and outcome. Cardiovasc Inter-vent Radiol 2011;34: 1190-8.
7. Vitek J. Idiopathic intractable epistaxis: endovascular therapy. Radiology 1991;181:113-6.
8. Tseng EY, Narducci CA, Willing SJ, et al. Angiographic embolization for epistaxis: a review of 114 cases. Laryngoscope 1998;108:615-9.
9. Oguni T, Korogi Y, Yasunaga T, et al. Superselective embolisation for intractable idiopathic epistaxis. Br J Radiol 2000;73:1148-53.
10. Duncan IC, Fourie PA, le Grange CE, et al. Endovascular treatment of intractable epistaxis–results of a 4-year local audit. S Afr Med J 2004;94:373-8.
11. Sadri M, Midwinter K, Ahmed A, et al. Assessment of safety and efficacy of arterial embolisation in the management of intractable epistaxis. Eur Arch Otorhinolaryngol 2006;263:560-6.
12. Fukutsuji K, Nishiike S, Aihara T, et al. Superselective angiographic embolization for intractable epistaxis. Acta Otolaryngol 2008;128:556-60.
13. Cullen MM, Tami TA. Comparison of internal maxillary artery ligation versus embolization for refractory posterior epistaxis. Otolaryngol Head Neck Surg 1998;118:636-42.
14. Wehrli M, Lieberherr U, Valavanis A. Superselective embolization for intractable epistaxis: experiences with 19 patients. Clin Otolaryngol Allied Sci 1988;13:415-20.
15. Elahi MM, Parnes LS, Fox AJ, et al. Therapeutic embolization in the treatment of intractable epistaxis. Arch Otolaryngol Head Neck Surg 1995;121:65-9.
16. Moreau S, De Rugy MG, Babin E, et al. Supraselective embolization in intractable epistaxis: review of 45 cases.Laryngoscope 1998;108:887-8.
17. Siniluoto TM, Leinonen AS, Karttunen AI, et al. Embolization for the treatment of posterior epistaxis. An analysis of 31 cases. Arch Otolaryngol Head Neck Surg 1993;119:837-41.
18. 18. de Vries N, Versluis RJ, Valk J, et al. Facial nerve paralysis following embolization for severe epistaxis (case report and review of the literature). J Laryngol Otol 1986;100:207–210.
19. Tan LK, Calhoun KH. Epistaxis. Med Clin North Am 1999;83:43-56.
20. Strutz J, Schumacher M. Uncontrollable epistaxis. Angiographic localization and embolization. Arch Otolaryngol Head Neck Surg 1990;116:697-9.
21. Metson R, Lane R. Internal maxillary artery ligation for epistaxis: an analysis of failures. Laryngoscope 1988;98:760-4.
22. Wang L, Vogel DH. Posterior epistaxis: comparison of treatment. Otolaryngol Head Neck Surg 1981;89:1001- 6.